Literature DB >> 14767602

Methods for volume assessment of prostate cancer.

Heinz-Peter Schlemmer1, Stefan Corvin.   

Abstract

This paper presents current knowledge on the prognostic significance of prostate cancer volume, reviews the feasibility of state-of-the-art imaging techniques for its assessment, and briefly introduces future perspectives regarding technical developments.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14767602     DOI： 10.1007/s00330-004-2233-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


  74 in total

1.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.

Authors:  G J Jager; E T Ruijter; C A van de Kaa; J J de la Rosette; G O Oosterhof; J R Thornbury; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

2.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

3.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.

Authors:  K K Yu; J Scheidler; H Hricak; D B Vigneron; C J Zaloudek; R G Males; S J Nelson; P R Carroll; J Kurhanewicz
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

4.  Percent of cancer in the biopsy set predicts pathological findings after prostatectomy.

Authors:  David J Grossklaus; Christopher S Coffey; Scott B Shappell; Gregory S Jack; Sam S Chang; Michael S Cookson
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

5.  A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics.

Authors:  T H Helbich; A Gossman; P A Mareski; B Radüchel; T P Roberts; D M Shames; M Mühler; K Turetschek; R C Brasch
Journal:  J Magn Reson Imaging       Date:  2000-06       Impact factor: 4.813

6.  Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.

Authors:  Herbert Augustin; Markus Graefen; Jüri Palisaar; Jakob Blonski; Andreas Erbersdobler; Fedor Daghofer; Hartwig Huland; Peter G Hammerer
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

7.  The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.

Authors:  C J Mettlin; G P Murphy; D S Rosenthal; H R Menck
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

8.  Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error.

Authors:  M Kojima; P Troncoso; R J Babaian
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

9.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Authors:  W J Catalona; D S Smith; R L Wolfert; T J Wang; H G Rittenhouse; T L Ratliff; R B Nadler
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

10.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.

Authors:  J I Epstein; M Carmichael; A W Partin; P C Walsh
Journal:  J Urol       Date:  1993-06       Impact factor: 7.450
View more
  3 in total

1.  Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?

Authors:  Nicolas Girouin; Florence Mège-Lechevallier; Alejandro Tonina Senes; Alvine Bissery; Muriel Rabilloud; Jean-Marie Maréchal; Marc Colombel; Denis Lyonnet; Olivier Rouvière
Journal:  Eur Radiol       Date:  2006-11-28       Impact factor: 5.315

2.  3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility study.

Authors:  Matthias P Lichy; Jörg Pintaske; Raimund Kottke; Jürgen Machann; Aristotelis Anastasiadis; Stefan Roell; Jörg Hennenlotter; Till Diergarten; Fritz Schick; Arnulf Stenzl; Claus D Claussen; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

Review 3.  [Prostate carcinoma].

Authors:  H-P Schlemmer
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.